CONSOLIDATED STATEMENT OF CHANGES IN STOCKHOLDERS' EQUITY (Unaudited) - USD ($)	Preferred Stock Series B	Preferred Stock Series C	Preferred Stock Series D	Preferred Stock Series E	Common Stock	Additional Paid-In Capital	Accumulated Deficit	Total
Balance, beginning at Dec. 31, 2018		$ 5	$ 2		$ 12,549	$ 12,171,274	$ (5,676,091)	$ 6,507,739
Balance, beginning (shares) at Dec. 31, 2018		4,662	2,000		12,549,394
Conversion of Series C		$ (1)			$ 1,900	(1,899)
Conversion of Series C (shares)		(1,026)			1,900,000
Dividend on Series D Preferred Stock						(40,000)		(40,000)
Stock-based compensation expense						60,920		60,920
Net loss							(565,465)	(565,465)
Balance, ending at Mar. 31, 2019		$ 4	$ 2		$ 14,449	12,190,195	(6,241,556)	5,963,194
Balance, ending (shares) at Mar. 31, 2019		3,636	2,000		14,449,394
Additional shares issued for acquisition					$ 175	(175)
Additional shares issued for acquisition (Shares)					175,000
Issuance of Common stock for consulting services					$ 550	189,950		190,500
Issuance of Common stock for consulting services (Shares)					550,000
Dividend on Series D Preferred Stock						(40,444)		(40,444)
Stock-based compensation expense						84,467		84,467
Net loss							(739,302)	(739,302)
Balance, ending at Jun. 30, 2019		$ 4	$ 2		$ 15,174	12,424,093	(6,980,858)	5,458,415
Balance, ending (shares) at Jun. 30, 2019		3,636	2,000		15,174,394
Balance, beginning at Dec. 31, 2019		$ 4	$ 2		$ 15,424	12,456,989	(8,198,785)	4,273,634
Balance, beginning (shares) at Dec. 31, 2019		3,501	2,000		15,424,394
Conversion of Series C		$ (1)			$ 350	(349)
Conversion of Series C (shares)		(189)			350,000
Purchase of Acquisition					$ (164)	164
Purchase of Acquisition (shares)					(164,375)
Dividend on Series D Preferred Stock						(40,445)		(40,445)
Stock-based compensation expense						54,635		54,635
Net loss							(403,273)	(403,273)
Balance, ending at Mar. 31, 2020		$ 3	$ 2		$ 15,610	12,470,994	(8,602,058)	3,884,551
Balance, ending (shares) at Mar. 31, 2020		3,312	2,000		15,610,019
Conversion of Series C		$ (3)			$ 13,248	(13,245)
Conversion of Series C (shares)		(3,312)			13,247,984
Conversion of Series D Preferred stock and accrued dividends			$ (2)		$ 3,500	200,502		204,000
Conversion of Series D Preferred stock and accrued dividends (Shares)			(1,890)		3,500,000
Conversion of Series D warrants					$ 2,948	(2,948)
Conversion of Series D warrants (Shares)					2,947,739
Issuance of Series E Preferred Stock, net of issuance costs				$ 1		1,009,999		1,010,000
Issuance of Series E Preferred Stock, net of issuance costs (Shares)				1,050
Repurchase of Series E Preferred stock						(1,110,880)		(1,110,880)
Repurchase of Series E Preferred stock (Shares)				(262)
Conversion of Series E Preferred stock				$ (1)	$ 3,152	(3,151)
Conversion of Series E Preferred stock (Shares)				(788)	3,152,000
Deemed dividend on Series C Preferred stock and Series D warrants						4,050,838	(4,050,838)
Deemed dividend on redemption of Series D Preferred stock						3,763,591	(3,763,591)
Sale of Common stock, net of issuance costs					$ 6,807	12,889,935		12,896,742
Sale of Common stock, net of issuance costs (Shares)					6,807,400
Sale of Common stock from conversion of pre-paid warrants					$ 3,260	7		3,267
Sale of Common stock from conversion of pre-paid warrants (Shares)					3,260,377
Issuance of Common stock for consulting services					$ 250	297,250		297,500
Issuance of Common stock for consulting services (Shares)					250,000
Exercise of options					$ 34	(34)
Exercise of options (Shares)					33,758
Stock-based compensation expense					$ 170	84,752		84,922
Stock-based compensation expense (Shares)					170,000
Net loss							(1,255,368)	(1,255,368)
Balance, ending at Jun. 30, 2020					$ 48,979	$ 33,637,610	$ (17,671,855)	$ 16,014,734
Balance, ending (shares) at Jun. 30, 2020			110		48,979,277